[Isoptin in the therapy of supraventricular arrhythmia in patients with diabetes mellitus, non-insulin dependent, concurrent with ischemic heart disease].
The article focuses on the action of isoptin as a monotherapy and in the complex with mildronat in 67 patients with non-insulindependent diabetes mellitus (NIDM) and supraventricular arrhythmia. Isoptin has been shown to be a very effective drug in patients with atrial disorders of cardiac rhythm suffering from diabetes mellitus and ischemic heart disease, especially so in a complex therapy with mildronat. The results obtained permit recommending isoptin as an antiarrhythmic drug in NIDM patients.
Potolochnaia
M D
MD
Burvalova
G I
GI
Pinchuk-Nikolaĭchuk
V P
VP
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000150:complications* / Q000188:drug therapy*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008763:Methylhydrazines / Q000627:therapeutic use; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications* / Q000188:drug therapy*; D014700:Verapamil / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D002317:Cardiovascular Agents; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate; D014700:Verapamil